Tag archive for ‘Valeant Pharmaceuticals International’
Alan Gallindoss On Wednesday, May 3rd, 2017

Bill Ackman lists £3.5 billion hedge fund in London as it looks for Brexit growth

Hedge fund manager Bill Ackman has listed his Pershing Square Holdings fund in London. The company launched a share buyback of the fund on Tuesday. Pershing Square’s listing on the London Stock Exchange More...

Niva Goldberg On Thursday, March 17th, 2016

Bill Ackman’s Pershing Square Sells $835 Million in Mondelez Shares

Bill Ackman’s said he sold nearly $835 million in shares of the snack food maker Mondelez. The announcement comes one day after Ackman’s hedge fund Pershing Square’s investment in Valeant More...

News Brief On Tuesday, March 1st, 2016

Bill Ackman Loses $321 Million in One Day After Valeant Plunges

Even for the beleaguered shareholders of Valeant Pharmaceuticals International Inc., Monday was an unusually bad day. The company’s biggest owner, investment firm Ruane Cunniff & Goldfarb, lost an estimated More...

News Brief On Friday, November 13th, 2015

Valeant, Ackman must face U.S. insider trading lawsuit

  A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before More...

Jewish Business News On Sunday, November 8th, 2015

Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says

  Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman Sachs to secure loans made to chairman and More...

News Brief On Sunday, October 4th, 2015

Warburg Pincus Said to Opt Out of Buying Brazilian Bank’s Shares – Bloomberg

 Warburg Pincus LLC, the New York-based private-equity firm, won’t buy more shares of Banco Indusval SA as the Brazilian bank sells stock to raise $20 million in capital, according to two people More...

Vered Weiss On Monday, March 9th, 2015

What Plans Does Bill Ackman Have for Valeant with his $3.3 Billion Stake?

Pershing Square’s Bill Ackman didn’t manage to make Valeant into a successful hunter, so one wonders, with his $3.3 billion stake, as reported by Reuters, will he make Valeant, like he did Allergan, More...

Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Reuters On Tuesday, November 18th, 2014

Ackman supports Allergan’s $66 billion sale to Actavis

– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...

Wordpress site Developed by Fixing WordPress Problems